Royalty Pharma (RPRX) PT Lowered to $44 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 67.18 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.18 | 52 Week High | $3.48 | |||
| Open | $67.18 | 52 Week Low | $0.80 | |||
| Day High | $67.18 | P/E | N/A | |||
| Day Low | $67.18 | EPS | $-1.54 | |||
| Volume | 149 | |||||
